Attached files

file filename
8-K - FORM 8-K - MEDCATH CORPd8k.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - MEDCATH CORPdex231.htm
EX-99.2 - FORM 10-K, ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA - MEDCATH CORPdex992.htm

Exhibit 99.1

Selected Financial Data

The following table sets forth our selected consolidated financial data as of and for the years ended September 30, 2010, 2009, 2008, 2007 and 2006.

 

     Year Ended September 30,  
     2010     2009     2008     2007     2006  

Consolidated Statement of Operations Data:

          

(in thousands, except per share data)

          

Net revenue

   $ 365,486      $ 327,204      $ 319,699      $ 379,577      $ 357,386   

Impairment of long-lived assets and goodwill

   $ 66,022      $ 42,000      $      $      $ 458   

(Loss) income from continuing operations before income taxes

   $ (65,960   $ (34,353   $ 26,047      $ 29,296      $ (937

(Loss) income from continuing operations, net of taxes

   $ (39,687   $ (33,307   $ 20,127      $ 8,364      $ (8,178

Income from discontinued operations, net of taxes

   $ 3,705      $ 552      $ 22,721      $ 3,163      $ 19,634   

Net (loss) income

   $ (48,371   $ (50,282   $ 20,990      $ 11,527      $ 12,576   

(Loss) earnings from continuing operations attributable to MedCath Corporation common stockholders per share, basic

   $ (2.55   $ (2.17   $ 0.34      $ 0.40      $ (0.44

(Loss) earnings from continuing operations attributable to MedCath Corporation common stockholders per share, diluted

   $ (2.55   $ (2.17   $ 0.34      $ 0.39      $ (0.42

(Loss) earnings per share, basic

   $ (2.44   $ (2.55   $ 1.05      $ 0.56      $ 0.67   

(Loss) earnings per share, diluted

   $ (2.44   $ (2.55   $ 1.04      $ 0.54      $ 0.64   

Weighted average number of shares, basic

     19,842        19,684        19,996        20,872        18,656   

Weighted average number of shares, diluted

     19,842        19,684        20,069        21,511        19,555   

Balance Sheet and Cash Flow Data:

          

(in thousands)

          

Total assets

   $ 494,538      $ 590,448      $ 653,456      $ 678,567      $ 785,849   

Total long-term obligations

   $ 99,841      $ 115,063      $ 121,875      $ 148,484      $ 274,962   

Net cash provided by operating activities

   $ 43,294      $ 63,633      $ 52,008      $ 58,225      $ 65,634   

Net cash (used in) provided by investing activities

   $ (16,956   $ (63,790   $ (5,805   $ (28,591   $ 10,064   

Net cash used in financing activities

   $ (41,009   $ (50,210   $ (78,028   $ (80,116   $ (22,165

Selected Operating Data (consolidated) (a):

          

Number of hospitals

     5        4        4        4        5   

Licensed beds (b)

     466        396        332        244        356   

Staffed and available beds (c)

     380        310        272        242        354   

Admissions (d)

     18,762        15,836        17,010        22,494        23,789   

Adjusted admissions (e)

     28,163        23,301        23,274        31,510        32,806   

Patient days (f)

     69,956        60,763        61,259        75,751        79,651   

Adjusted patient days (g)

     105,467        89,281        83,541        105,680        109,670   

Average length of stay (h)

     3.73        3.84        3.60        3.37        3.35   

Occupancy (i)

     50.4     53.7     61.7     85.8     61.6

Inpatient catheterization procedures (j)

     7,986        7,348        9,048        10,481        10,372   

Inpatient surgical procedures (k)

     4,555        4,200        3,975        5,154        5,321   

Hospital net revenue

   $ 362,552      $ 324,286      $ 316,389      $ 375,037      $ 351,669